Prehospital Massive Transfusion for Resuscitation of an Entrapped Patient in a Rural Setting: A Case Report.

Resuscitation of injured patients suffering from hemorrhagic shock with blood products in the prehospital environment is becoming more commonplace. However, blood product utilization is typically restricted and can be exhausted in the event of a prolonged entrapment. Delivery of large amounts of blood products to a scene is rare, particularly in rural settings. We present the case of a 26-year-old male who was entrapped in a motor vehicle for 144 min. First responders assessed the entrapped patient to be in hemorrhagic shock from lower extremities injuries. The Helicopter Emergency Medical Services team exhausted their supply of blood products shortly after arrival on scene. The local trauma center's Surgical Emergency Response Team (SERT) was requested to the scene. The preplanned response included seven units of blood components to provide massive transfusion at the point of injury and released directly to field responders by the blood bank. During extrication, the patient was given two units of packed red blood cells by initial responders with three more units of blood components from the SERT supply. During transfer to the hospital, the patient received an additional three units, and four units were transfused on initial trauma resuscitation in the hospital. He was found to have severe lower extremities injuries as the cause of his hemorrhage. The patient survived to hospital discharge. Delivery of large volumes of blood products to an entrapped patient with prolonged extrication time may be a lifesaving intervention. We advocate for integration of blood bank services and on scene physician guided resuscitation for prolonged extrications.

Prehospital portable ultrasound for safe and accurate prehospital needle thoracostomy: a pilot educational study.

BACKGROUND: Simulated needle thoracostomy (NT) using ultrasound may reduce potential injury, increase accuracy, and be as rapid to perform as the traditional landmark technique following a brief educational session. Our objective was to determine if the use of an educational session demonstrating the use of handheld ultrasound to Emergency Medical Services (EMS) staff to facilitate NT was both feasible, and an effective way of increasing the safety and efficacy of this procedure for rural EMS providers. METHODS: A pre/post-educational intervention on a convenience sample of rural North American EMS paramedics and nurses. Measurement of location and estimated depth of placement of needle thoracostomy with traditional landmark technique was completed and then repeated using handheld ultrasound following a training session on thoracic ultrasound and correct placement of NT. RESULTS: A total of 30 EMS practitioners participated. Seven were female (23.3%). There was a higher frequency of dangerous structures underlying the chosen location with the landmark technique 9/60 (15%) compared to the ultrasound technique 1/60 (1.7%) (p = 0.08). Mean time-to-site-selection for the landmark technique was shorter than the ultrasound technique at 10.7 s (range 3.35-45 s) vs. 19.9 s (range 7.8-50 s), respectively (p < 0.001). There was a lower proportion of correct location selection for the landmark technique 40/60 (66.7%) when compared to the ultrasound technique 51/60 (85%) (p = 0.019). With ultrasound, there was less variance between the estimated and measured depth of the pleural space with a mean difference of 0.033 cm (range 0-0.5 cm) when ultrasound was used as compared to a mean difference of 1.0375 cm (range 0-6 cm) for the landmark technique (95% CI for the difference 0.73-1.27 cm; p < 0.001). CONCLUSIONS: Teaching ultrasound NT was feasible in our cohort. While time-to-site-selection for ultrasound-guided NT took longer than the landmark technique, it increased safe and accurate simulated NT placement with fewer identified potential iatrogenic injuries.

EMS agencies with high rates of field termination of resuscitation and longer scene times also have high rates of survival.

AIM: Out-of-hospital cardiac arrest (OOHCA) management dichotomizes strategies to (1) "scoop-and-run" to a higher level of care or (2) "treat on the X" with the goal of return of spontaneous circulation (ROSC) before transport, with field termination of resuscitation (FTOR) of unsuccessful resuscitations. We hypothesized that EMS agencies with greater average time on-scene and higher rates of field termination of resuscitation would have more favorable outcomes. METHODS: The Cardiac Arrest Registry to Enhance Survival (CARES) was used to identify OOHCA cases from 2013 to 2018. Agencies in the top and bottom quartiles of on-scene time were categorized as high (HiOST) and low (LoOST); in the top and bottom quartiles of field termination rate were categorized as high (HiTOR) and low (LoTOR). Generalized estimating equation models compared top and bottom quartiles. RESULTS: We classified 95 agencies as HiOST (average > 25.1 min) or LoOST (average < 19.3 min). We classified 95 agencies as HiTOR (average > 46.5% FTOR) or LoTOR (average < 23.5% FTOR). Controlling for agency characteristics, HiOST had a higher survival to discharge for transported patients (28.1% vs 23.1%, OR = 2.8, 95 %CI 2.1-3.6, p < 0.001), ROSC on emergency department arrival, and favorable neurologic outcome than LoOST. HiTOR had a higher survival to discharge for transported patients (25.6% vs 19.3%, OR = 3.3, 95 %CI 2.5-4.4, p < 0.001), ROSC on emergency department arrival, and favorable neurologic outcome than LoTOR. CONCLUSION: EMS agencies with higher rates of FTOR and longer on-scene times for patients with OOHCA have higher overall patient survival, ROSC, and favorable neurologic function.

Helicopter Emergency Medical Services Transport of COVID-19 Patients in the "First Wave": A National Survey.

Study objectives Helicopter emergency medical services (HEMS) providers have had to adjust to transporting patients with a novel, highly infectious pathogen. This study describes how HEMS organizations in the USA approached the coronavirus disease 2019 (COVID-19) pandemic in its first wave. Methods A survey was distributed via REDCap™ to HEMS organizations in May of 2020 using a national database. Data were collected regarding agency demographics and COVID-19 practices, including education, risk assessment, protective measures, equipment use, and decontamination practices. These were analyzed for qualitative observations and program attributes for COVID transport. Results A total of 68/287 (24%) organizations responded and completed the survey. Eighty-five percent (85%) of responding programs reported that they chose to transport known or suspected COVID-19 patients by air medical transport. Of responding programs, 93% provided education to their providers regarding COVID-19 and 100% conducted a COVID-19 risk analysis for patient transports. Of agencies transporting known or suspected COVID-19 patients, 77% required the use of N95 filtering facepiece respirators (N95) or powered air-purifying respirators (PAPR) for crewmembers during known or suspected COVID-19 patient transfers and 95% provided N95 respirators for pilots during transport. Five percent of responding programs utilized portable negative pressure isolation units. For COVID-19 transporting and non-transporting agencies, when transporting non-COVID-19 known or suspected patients, personal protective equipment (PPE) practice varied but tended to be more relaxed. Some services separated pilots from providers even during downtime (29%). Among services transporting known or suspected COVID-19 patients, the most common decontamination practice was manual wipe-down of all surfaces for a downtime of less than two hours. Conclusion The majority of survey respondents report that their programs chose to transport patients with known or suspected COVID-19 by air medical transport. However, there was high variability in practices regarding the transport of known or suspected COVID-19 as well as that of non-COVID-19 known or suspected patients by air during the initial outbreak of the pandemic. The HEMS industry may benefit from further research and standardization of airborne highly infectious disease transport practices in preparation for the next respiratory virus pandemic.